CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Est. Return
8.19%
This Fund
S&P 500
1 Year Est. Return
-8.19%
AUM
$718M
AUM Growth
-$885M
(-55%)
Holding
35
Top Buys
| 1 | +$42.6M | |
| 2 | +$39.7M | |
| 3 | +$38.2M | |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$15.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$5.89M |
Top Sells
| 1 | +$121M | |
| 2 | +$106M | |
| 3 | +$87.9M | |
| 4 |
CVS Health
CVS
|
+$78.7M |
| 5 |
PTC Therapeutics
PTCT
|
+$76.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$15.9B
| $91.2M | 12.71% |
1,000,000
-1,250,000
|
|
||
2
Baxter International
BAX
$9.7B
| $86.3M | 12.02% |
2,850,000
-2,900,000
|
|
||
3
Humana
HUM
$36.7B
| $73.3M | 10.22% |
300,000
-425,000
|
|
||
|
4
CVS Health
CVS
$116B
| $72.4M | 10.09% |
1,050,000
-1,200,000
|
|
||
5
Globus Medical
GMED
$11.1B
| $47.2M | 6.58% |
800,000
-450,000
|
|
||
6
Icon
ICLR
$10.4B
| $43.6M | 6.08% |
+300,000
|
|
||
7
Ascendis Pharma A/S
ASND
$13.8B
| $43.1M | 6.01% |
250,000
-100,000
|
|
||
8
Merck
MRK
$293B
| $39.6M | 5.51% |
+500,000
|
|
||
9
Pfizer
PFE
$149B
| $36.4M | 5.06% |
1,500,000
-1,000,000
|
|
||
|
10
BioMarin Pharmaceuticals
BMRN
$11.1B
| $33M | 4.59% |
600,000
+100,000
|
|
||
11
UnitedHealth
UNH
$345B
| $31.2M | 4.35% |
+100,000
|
|
||
12
Viatris
VTRS
$18.9B
| $24.6M | 3.42% |
2,750,000
-4,750,000
|
|
||
13
Brookdale Senior Living
BKD
$3.07B
| $15M | 2.08% |
2,150,000
-4,100,000
|
|
||
|
ZIMV
14
DELISTED
ZimVie
ZIMV
| $15M | 2.08% |
1,600,000
-285,000
|
|
||
|
APLS
15
DELISTED
Apellis Pharmaceuticals
APLS
| $14.7M | 2.05% |
+850,000
|
|
||
16
Myriad Genetics
MYGN
$375M
| $10.6M | 1.48% |
2,000,000
-350,000
|
|
||
17
Evolent Health
EVH
$444M
| $9.57M | 1.33% |
850,000
-2,150,000
|
|
||
|
CON
18
Concentra Group Holdings
CON
$3.18B
| $8.23M | 1.15% |
400,000
-1,200,000
|
|
||
19
Inogen
INGN
$176M
| $6.85M | 0.95% |
975,000
|
|
||
20
Denali Therapeutics
DNLI
$3.34B
| $5.6M | 0.78% |
400,000
-850,000
|
|
||
21
Theravance Biopharma
TBPH
$828M
| $4.96M | 0.69% |
450,000
-550,000
|
|
||
22
AnaptysBio
ANAB
$1.62B
| $2.77M | 0.39% |
125,000
-625,000
|
|
||
23
OraSure Technologies
OSUR
$296M
| $2.7M | 0.38% |
900,000
|
|
||
24
State Street SPDR S&P Biotech ETF
XBI
$8.54B
| – | – |
0
|
|
||
25
10x Genomics
TXG
$3.59B
| – | – |
-1,000,000
|
|